Advanced search
Publication Cover
Diabetes, Metabolic Syndrome and Obesity Volume 15, 2022 - Issue
Submit an article Journal homepage
411
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Difference in Gastrointestinal Risk Associated with Use of GLP-1 Receptor Agonists: A Real-World Pharmacovigilance Study

Yu Zhou1 Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, People’s Republic of ChinaView further author information
,
Mingyu Chen1 Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, People’s Republic of ChinaView further author information
,
Libin Liu2 Department of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, People’s Republic of ChinaView further author information
&
Zhou Chen1 Department of Clinical Pharmacy and Pharmacy Administration, School of Pharmacy, Fujian Medical University, Fuzhou, People’s Republic of ChinaCorrespondence[email protected] [email protected]
View further author information
Pages 155-163 | Published online: 13 Jan 2022

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

António Cabral Lopes, Fátima Roque, Olga Lourenço, Maria Teresa Herdeiro & Manuel Morgado. (2023) Gastrointestinal disorders potentially associated with Semaglutide: an analysis from the Eudravigilance Database. Expert Opinion on Drug Safety 22:6, pages 455-461.
Read now

Articles from other publishers (5)

Qian-Qian Zhou, Hai-Tao Xiao, Fan Yang, Yong-Dan Wang, Ping Li & Zu-Guo Zheng. (2023) Advancing targeted protein degradation for metabolic diseases therapy. Pharmacological Research 188, pages 106627.
Crossref
Hao Wu, Zongshi Lu, Runyao Chen, Quanfang Cai, Miaomiao Wang, Liting Zhang & Zhiming Zhu. (2023) Factors associated with gastrointestinal side effects after liraglutide treatment for type 2 diabetes. Frontiers in Endocrinology 14.
Crossref
Lulu Liu, Jia Chen, Lei Wang, Chen Chen & Li Chen. (2022) Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: A real-world disproportionality study based on FDA adverse event reporting system database. Frontiers in Endocrinology 13.
Crossref
Yamin Shu, Xucheng He, Pan Wu, Yanxin Liu, Yufeng Ding & Qilin Zhang. (2022) Gastrointestinal adverse events associated with semaglutide: A pharmacovigilance study based on FDA adverse event reporting system. Frontiers in Public Health 10.
Crossref
. (2022) Semaglutide and liraglutide have differing gastrointestinal ADR profiles. Reactions Weekly 1891:1, pages 12-12.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.